Peripheral Neuropathies
Neuropathies associated with cytomegalovirus infection
Nov. 16, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Arboviral encephalitis …
- Updated 03.14.2024
- Released 05.26.1994
- Expires For CME 03.14.2027
Arboviral encephalitis
Introduction
Overview
Arboviruses are members of a group of animal viruses that multiply in an arthropod (mosquitoes, ticks, and sandflies) and are transmitted to a vertebrate host, including humans. Some arboviruses may cause encephalomyelitis in a minority of infected humans, whereas a mild systemic illness associated with fever is a more common manifestation of infection. West Nile virus infection is currently the largest problem in the United States. In this update, the author reviews the clinical features, pathogenesis, epidemiology, diagnosis, and management of arboviral encephalitis.
Key points
|
• Most infections caused by arboviruses are asymptomatic or only cause mild systemic disease. | |
|
• Vaccines are available for the prevention of some of the arboviruses that cause encephalitis; otherwise, preventative measures should be focused on prevention of mosquito and tick bites. | |
|
• Laboratory diagnosis of arboviral encephalitis is based on antibody testing on sera and CSF, and on detection of nucleic acids in CSF. | |
|
• Therapy of arboviral encephalitis is symptomatic except in clinical trials. |
Historical note and terminology
Arboviruses (an acronym for arthropod-borne viruses) are members of a group of animal viruses that multiply in an arthropod and are transmitted to a vertebrate host (18). In the 1950s, the Rockefeller Foundation established a network of laboratories around the world, which facilitated the identification of arboviral diseases. Some of the arboviruses were given names of the places where they were first isolated (eg, St. Louis encephalitis virus, Japanese encephalitis virus, and California encephalitis virus). These names do not imply that the infections are a problem in these locations at the present time. In fact, only a single case of encephalitis due to California encephalitis virus has been reported in California during the past 50 years (37).
Many of the arboviruses were isolated in the 1930s, although their diseases may have been recognized much earlier. Immature rodents were commonly used for viral isolation. Later, cell culture was also used. Epizootics of eastern equine encephalitis in horses occurred as far back as 1831 (53). There were epidemics of Japanese encephalitis in Japan as far back as 1870, and an epidemic in 1924 caused 3797 deaths (14). No epidemics have occurred in Japan since the 1960s. An epidemic of western equine encephalitis in 1941 resulted in more than 3300 human cases (110). In 1971, there was a large epidemic of Venezuelan equine encephalitis in Mexico and the United States (35), and a large epidemic of St. Louis encephalitis occurred in the United States and Canada in 1975 (85). The emergence and re-emergence of epidemic arboviral disease has been a public health problem in past years (116) and will continue to be a problem in the future. The incursion of West Nile virus infection into North America in 1999 was an important event, and it is expected that variable numbers of human cases will occur on this continent for many decades or centuries in the future.
Clinical manifestations
Presentation and course
|
• Arboviral infections are often mild or inapparent infections. | |
|
• Some arboviruses cause encephalitis or myelitis, and acute flaccid paralysis may occur. |
Arboviruses commonly cause inapparent infections or mild nonspecific illnesses. A minority of patients (the number varies with the specific arbovirus) develop acute encephalitis (or encephalomyelitis), meningitis, or a combination of both. Clinical illness usually develops in arboviral infections a few days after transmission of the arbovirus from the bite of a mosquito or tick vector. Patients with meningitis have fever, headache, neck stiffness, and signs of meningeal irritation; this presentation is less common than encephalitis. Patients with encephalitis may have fever, a depressed level of consciousness (ranging from drowsiness to coma), seizures, or focal neurologic signs (62; 66). Focal signs are only occasionally prominent in arboviral encephalitis (104). Patients may also have evidence of spinal cord involvement (94; 82). Acute flaccid paralysis has been noted in patients with West Nile encephalitis, and ventilatory support may be required (115). Cases with muscle weakness often have ventral horn cell involvement due to West Nile, Powassan, Japanese, and other arboviral infections (82; 103; 45), and rare patients have features of an atypical Guillain-Barré syndrome (01). Both delayed-onset and recurrent limb weakness occurring several weeks after illness have rarely been observed in West Nile virus infection (114). Acute flaccid paralysis has also been reported in Japanese encephalitis virus infection (131); movement disorders may also occur. In West Nile encephalitis, movement disorders include tremor, opsoclonus-myoclonus, parkinsonism, myoclonus, ataxia, and chorea, and the movement disorder usually resolves within a few weeks to months (80). Seizures and raised intracranial pressure may be important causes of death (131).
The severity of encephalitides caused by arboviruses ranges from mild to severe and fatal. The frequency and severity of neurologic sequelae are also variable. Certain arboviruses typically cause more severe disease and higher fatality rates than others. For example, eastern equine encephalitis virus causes a severe encephalitis with a mortality rate of about 70%. In contrast, La Crosse virus causes a relatively mild encephalitis (California serogroup encephalitis) with a low fatality rate. Arboviruses may cause disease in certain age groups. Encephalitis caused by La Crosse virus usually occurs in children, although infection can occur at any age. Adults in epidemic areas seldom develop Japanese encephalitis because they have developed immunity from childhood infection. Infants often have severe sequelae from western equine encephalitis (33), and elderly patients are more likely to have severe sequelae from St. Louis encephalitis (41). Risk factors for severe West Nile virus disease, including encephalitis, are chronic renal disease, a history of cancer, a history of alcohol abuse, diabetes, and hypertension (83). West Nile virus infection may be particularly severe in organ transplant recipients (74).
Zika virus infection does not commonly cause encephalitis but is associated with microcephaly of the fetus and infant after infection of pregnant women; the infection has also been associated with Guillain-Barré syndrome (16; 13; 113). A case of Zika virus infection was reported from Colombia with acute disseminated encephalomyelitis and Guillain-Barré syndrome, likely due to boosted immunity to other arboviruses (87).
Prognosis and complications
|
• Arboviral infections may be fatal, and neurologic sequelae may be severe. | |
|
• Arboviral encephalitis may trigger autoimmune encephalitis. |
Focal or generalized seizures may occur in the acute phase of arboviral encephalitis. Hyponatremia due to inappropriate secretion of antidiuretic hormone is particularly frequent in St. Louis encephalitis (12). Dehydration, respiratory complications, nosocomial infections, and decubitus ulcers may occur in these acutely ill patients.
The morbidity and mortality vary in encephalitides caused by different arboviruses. Recovery from neurologic sequelae of West Nile virus infection, including cognitive deficits and weakness, may be prolonged and incomplete (28). The mortality rate is highest (about 35%) in eastern equine encephalitis, where neurologic sequelae are common and may be severe, especially in children (39; 105; 30). The average lifetime cost to a person with sequelae approaches $3 million (133). The mortality rate is about 10% in western equine encephalitis, and sequelae are moderate in infants, including mental retardation, seizure disorders, and motor impairment. Sequelae are low in other age groups (33). The mortality rate is low in Venezuelan equine encephalitis, in La Crosse encephalitis, and in encephalitis due to Colorado tick fever virus; neurologic sequelae are infrequent and usually mild. However, a fatal case of La Crosse encephalitis occurred in Minnesota in 1997 (21). Seizure disorders may occur after La Crosse encephalitis (29). In St. Louis encephalitis, the mortality rate increases from 2% in young adults to 20% in the elderly, and sequelae are more common and more severe in patients over 50 years of age (41). In Japanese encephalitis, one third of patients die, whereas half of the survivors have severe neuropsychiatric sequelae (122). Many children have been reported to develop relapsing illness after Japanese encephalitis and have NMDA receptor antibodies in CSF (86). Hence, like herpes simplex encephalitis, arboviral encephalitis may also be a trigger for the development of autoimmune encephalitis. The Far Eastern form of tick-borne encephalitis is more severe than the Central European form; the mortality rate is up to 20%, and sequelae are frequent (32). Epilepsia partialis continua may develop during the convalescent period or later (05), and there may be residual weakness due to bulbar or cervical cord involvement (117). Japanese encephalitis has a mortality rate of almost 50% in patients over 50 years of age and less than 20% in children (99). Sequelae occur in 30% to 40% of patients between 5 and 40 years of age (135) and include extrapyramidal features (especially dystonia), flaccid paralysis, and seizure disorders (122).
Clinical vignette
A 10-year-old boy from Illinois had fever, vomiting, headache, and confusion for a period of 2 days. He had two generalized convulsions and was hospitalized. On examination, his temperature was 38.2°C, and he had moderate nuchal rigidity. He was stuporous, but there was no focal weakness, and his deep tendon reflexes were normal. A CT head scan was normal. Cerebrospinal fluid analysis showed a pleocytosis with 120 leukocytes (95% mononuclear cells) and an elevated protein of 70 mg/mL. An EEG showed diffuse slowing but no epileptiform activity. He received antiepileptic therapy and made a complete recovery over a period of 2 weeks. The titer of neutralizing antibody against La Crosse virus in acute serum was less than 1:8, and it was 1:64 in convalescent serum; this confirmed a diagnosis of California serogroup (La Crosse) encephalitis.
Biological basis
Etiology and pathogenesis
|
• Arboviruses have an obligatory cycle in arthropod vectors. | |
|
• Arboviruses are RNA viruses from different viral families. | |
|
• Arboviruses spread to the CNS via a hematogenous route. |
More than 20 arboviruses that cause human encephalitis have been identified (65). The arboviruses are transmitted to vertebrate hosts after an obligatory cycle in hematophagous arthropods, including mosquitoes, ticks (130), and sandflies (07).
Humans are not necessary for the maintenance of arboviruses in nature. Arboviruses are the most common cause of epidemic encephalitis, and they are also responsible for other diseases, including yellow fever and hemorrhagic fevers. Although encephalopathy is more common, dengue virus infection may rarely cause encephalitis or other neurologic complications (132). The arboviruses are enveloped RNA viruses from different families, including the Togaviridae (Alphavirus genus), Flaviviridae (Flavivirus genus), Bunyaviridae (Bunyavirus genus), and Reoviridae (Orbivirus genus); these are transmitted to humans by a mosquito, tick, or, rarely, sandfly vector.
Table 1. Arthropod-Borne Viruses Causing Encephalitis
|
Virus (genus) |
Vector |
Vertebrate Reservoir |
Geographic Distribution |
|
Eastern equine (alphavirus) |
A. sollicitans |
Birds |
Eastern and Gulf coasts of the United States, Caribbean |
|
Western equine (alphavirus) |
C. tarsalis |
Birds |
Western United States |
|
Venezuelan equine (alphavirus) |
Many mosquito species |
Horses, small mammals |
South and Central America |
|
Chikungunya (alphavirus) |
Aedes mosquitoes |
Wild primates |
Africa, Asia, Europe, the Americas |
|
St. Louis (flavivirus) |
C. pipiens, C. tarsalis |
Birds |
Widespread in United States |
|
Japanese (flavivirus) |
C. taeniorhynchus |
Birds |
Asia |
|
West Nile (flavivirus) |
Culex and Aedes species |
Birds |
Africa, Asia, Europe, widespread in North America |
|
Usutu (flavivirus) |
Culex and Aedes species |
Birds |
Africa, Europe, Middle East |
|
Zika* (flavivirus) |
Aedes mosquitoes |
Probably nonhuman primates |
South and Central America, Africa, Asia |
|
Far Eastern tick-borne (flavivirus) |
I. persulcatus (tick) |
Small mammals, birds |
Former eastern USSR |
|
Central European tick-borne (flavivirus) |
I. ricinus (tick) |
Small mammals, birds |
Central Europe |
|
Powassan (flavivirus) |
I. cookei (tick) and I. marxi (ticks) |
Small mammals |
Canada, northern United States |
|
Deer tick (flavivirus) |
I. scapularis (tick) |
Small mammals |
Canada, northern United States |
|
La Crosse (bunyavirus) |
A. triseriatus |
Small mammals |
Central United States |
|
Jamestown Canyon (bunyavirus) |
Many mosquito species |
Various mammals |
Northeastern, Midwestern, and Western United States |
|
Colorado tick fever (orbivirus) |
D andersoni (tick) |
Small mammals |
Rocky Mountain area of United States |
|
Cache Valley (bunyavirus) |
Many mosquito species |
Deer and other mammals |
North America |
|
| |||
Arboviruses are ingested into the gut of the arthropod vector and replication occurs in its tissues. This infection is not usually associated with any cytopathology or detrimental effects on the vector (130). There is viral spread to the salivary glands of the arthropod, and transmission occurs to the vertebrate host, including humans, during probing or blood-feeding. After inoculation through the skin of the host, viral replication occurs close to the site of entry in subcutaneous tissues or muscle (02). This infection results in a high-titer viremia and dissemination to the CNS via the bloodstream. Transmission of arboviruses may also occur through transfusion of blood or blood components (46). There is either infection of CNS endothelial cells or the virus is transported across endothelial cells. Toll-like receptor 3 has been shown to be involved in brain penetration by West Nile virus (134). Cell-to-cell spread of the virus occurs in the CNS. Neurons are prominently infected, and there is variable involvement of other neural cells. The infection causes cytopathic changes in CNS cells and inflammatory changes, including infiltration of the leptomeninges and perivascular spaces with mononuclear cells. Individual arboviruses may be associated with different topographic distributions of pathological changes. For example, the West Nile virus characteristically involves the brainstem (111) and spinal cord or ventral nerve roots (82), causing flaccid paralysis. There is experimental evidence that arboviruses can induce apoptotic cell death in neurons in the brains of their hosts (81; 63). The infection may result in the death of the host, or there may be immune system-mediated clearance of the viral infection with complete recovery or neurologic sequelae (50). CNS involvement, sometimes with probable CNS invasion, may also occur in dengue virus (a flavivirus) infection, especially in fatal cases (03). Like herpes simplex encephalitis, there are reports that anti-N-methyl-D-aspartate receptor encephalitis may be associated with both Japanese encephalitis virus infection (127), tick-borne encephalitis virus infection (17), and chikungunya virus infection (98).
Epidemiology
|
• Arboviral infections may occur in epidemics or as sporadic cases. | |
|
• Numbers of cases vary from year to year related to environmental factors. |
Arboviral infections may occur either in epidemics or sporadically. There are complex ecological cycles between arthropod vectors and their natural hosts; this explains the geographic and seasonal (usually in the summer and early fall) occurrence of these infections (75). Outbreaks of arboviral encephalitis are often focal in their distribution, and specific arboviruses usually cause infections in particular geographic areas.
Epidemics of eastern equine encephalitis are relatively small and mostly occur in the eastern part of the United States. From 2003 to 2022, 4 to 38 human cases were reported in the United States each year. Western equine encephalitis occurs in the western United States and in Canada. Only three human cases of western equine encephalitis were reported in the United States during the 1990s (21), and none have been reported in recent years. Venezuelan equine encephalitis has occurred in large outbreaks in Central and South America. In 1971, a large epidemic in Mexico crossed the Texas border (35). In 1995, there was a large epidemic of Venezuelan equine encephalitis in Venezuela and Columbia (19; 20). In Venezuelan equine encephalitis, the horse is an important amplifying host, whereas in eastern and western equine encephalitis, the horse, like humans, is a dead-end host. St. Louis encephalitis has both urban and rural outbreaks. In 1975 an epidemic caused cases in 30 U.S. states and in Canada (85). The activity of St. Louis encephalitis virus infection decreased in the United States after the introduction of West Nile virus in 1999. There was an outbreak in Arizona from 2014 to 2015, and there were isolated cases in California from 2016 through 2017 (31). Chikungunya virus infection, which occurs in Africa, Asia, Europe, and more recently in the Americas (including Florida, Puerto Rico, and U.S. Virgin Islands), causes fever, rash, and arthralgias and can also cause encephalitis (43). Sporadic cases of Powassan encephalitis have been recognized in the northern United States and Canada (Ontario and Quebec), and the incidence is increasing (04; 44; 56; 34). The distribution of the disease has spread from the northeastern United States to involve the upper midwestern United States. There has been an increase in incidence, with 99 human cases reported in the United States from 2006 to 2016 (77). Powassan virus is transmitted by Ixodes ticks, and infections are sporadic. In 2009, fatal human encephalitis was reported in New York due to infection by another tick-borne encephalitis virus called deer tick virus (125). This virus is identical to the Powassan virus according to conventional taxonomic criteria (34). In Europe and Russia, about 10,000 cases of tick-borne encephalitis are reported annually; cases may occur in travelers (49). The incidence and geographical range of the disease is increasing in Europe and Asia (79). The severity of tick-borne encephalitis increases with age (68). Most cases of California serogroup encephalitis are caused by the La Crosse virus and occur in the central United States. There were 70 to 167 cases yearly from 1999 to 2007 (109). Most cases of La Crosse encephalitis occur in children, but adult cases have occasionally been recognized (126). Other California serogroup viruses less commonly cause encephalitis, including the Jamestown Canyon virus (26). The distribution of Jamestown Canyon virus infection is more widespread in the United States. California serogroup viral encephalitis has been the most under-recognized arboviral encephalitis in the United States (21).
Japanese encephalitis is the most common cause of epidemic encephalitis in the world, and now almost half of the human population lives in countries where the disease is endemic (38). Large summer epidemics and endemic disease in Asia is responsible for about 50,000 cases per year, with case fatality rates of about 25% (48). Infection should be considered by travelers to endemic areas. Japanese encephalitis virus is transmitted by the mosquito Culex tritaeniorhynchus, which breeds in rice fields. Water birds are natural hosts, and pigs may be important amplifying hosts in many countries.
In 1999, West Nile virus was responsible for an outbreak of encephalitis in New York City and neighboring counties with 62 cases and seven deaths (22). The mechanism of the virus’ introduction into North America is unknown. The virus quickly moved across the North American continent. In 2023, there were 2406 cases of West Nile virus infection, including 1599 (66%) with neuroinvasive disease. Elderly and immunosuppressed patients are particularly at risk for disease and a fatal outcome. Transmission may also occur by organ transplantation, infected blood products, and breast milk.
Prevention
|
• Personal measures are useful in preventing arthropod bites and the development of infections. | |
|
• Vaccines have been developed for some arboviral infections in humans and animals. |
Surveillance methods are important to predict the likelihood of outbreaks of infections (36). Environmental factors can be monitored. Mosquitoes can be sampled to estimate population levels, and infection rates can be assessed in mosquito pools. Recognition of infections and disease in sentinel hosts such as horses before disease occurs in humans is important. Sentinel chickens can be bled periodically to determine seroconversion, which indicates increased activity of an arbovirus.
Personal measures, including screening, protective clothing, and repellents, are useful in the prevention of arthropod bites and the subsequent development of arboviral infections. Avoiding outdoor activities at dusk, when mosquitoes are most active, is also useful. Prompt removal of ticks from the skin may decrease the risk of transmission of a tick-borne virus. Public health measures include modification of irrigation practices, which can eliminate aquatic habitats that are breeding places for mosquitoes. Effective preventive measures for California serogroup (La Crosse) encephalitis include removing water-holding containers, especially discarded tires, and filling basal tree holes (42). The application of insecticides may be useful in the emergency control of infected mosquitoes.
Vaccines are available for eastern equine encephalitis, western equine encephalitis, Venezuelan equine encephalitis, and West Nile encephalitis in horses. A live attenuated vaccine (TC-83) has been used to protect laboratory and field workers from Venezuelan equine encephalitis virus infection (96). Vaccines have also been developed for Japanese encephalitis (124; 121) and tick-borne encephalitis (54), and adverse effects of these vaccines must be considered (88).
Differential diagnosis
Confusing conditions
Arboviral encephalitis may be clinically indistinguishable from other forms of viral encephalitis. Focal neurologic signs are not usually prominent, but they may be present. In Herpes simplex encephalitis, evidence of focal brain involvement (especially in the temporal lobes) is often obtained by clinical assessment and by using electroencephalography and imaging techniques (CT, MRI). These investigations may help differentiate between Herpes simplex encephalitis and arboviral encephalitis (95). In addition, detecting Herpes simplex virus DNA in the cerebrospinal fluid with polymerase chain reaction amplification is an important diagnostic test for Herpes simplex encephalitis. The mortality rate in untreated Herpes simplex virus encephalitis is about 70% (137).
Although enteroviruses more commonly cause aseptic meningitis, they may also cause encephalitis. Enteroviral infections also peak in the summer and early fall. They may be associated with a rash (72), and there may be a history of recent illness in the family. Enteroviral encephalitis is usually mild, with a good recovery.
Other viruses that cause encephalitis include mumps virus, lymphocytic choriomeningitis virus, Epstein-Barr virus, cytomegalovirus, adenovirus, and rabies virus. Nonviral infections include brain abscess, leptospirosis, Lyme disease, Rocky Mountain spotted fever, toxoplasmosis, and malaria. Postinfectious encephalomyelitis (67) and noninfectious diseases, including metabolic and septic encephalopathy (09), neurosarcoidosis, and neoplasms, should also be considered in the differential diagnosis.
Diagnostic workup
|
• Laboratory diagnosis is based on antibody testing on sera and CSF and on detection of nucleic acids in CSF. | |
|
• Neuroimaging may be helpful for diagnosis and for exclusion of other diseases. |
Routine laboratory studies are not usually helpful in establishing a diagnosis of arboviral encephalitis. Electroencephalograms often show generalized slowing, although epileptiform activity or periodic lateralizing epileptiform discharges (92) may be present. The results of imaging techniques, including CT and MRI scans, have not been reported frequently. Many patients with West Nile neuroinvasive disease have normal neuroimaging, but abnormalities may be demonstrated in the basal ganglia, thalamus, brainstem, and cerebellum (28; 08). CT or MRI scans have demonstrated lesions in the basal ganglia, thalamus, and brainstem in eastern equine encephalitis (30; 06). Powassan encephalitis may show cortical (107) or thalamic hemorrhages (25). In Japanese encephalitis, MRI scans show lesions in the thalami in most patients; lesions also occur in the basal ganglia, midbrain and pons, cerebral cortex, and cerebellum (78; 70; 51), and lesions may be hemorrhagic (112). T2 and fluid-attenuated inversion recovery (FLAIR) images are more sensitive (51). Temporal lobe lesions mainly involve the hippocampus and spare the rest of the temporal lobe and are associated with concurrent involvement of thalami and substantia nigra, which allows differentiation from Herpes simplex encephalitis (52). MRI lesions may be present in the thalamus, basal ganglia, and brainstem in tick-borne encephalitis (89). MR FLAIR axial imaging may show the “parenthesis sign” with marked linear hyperdensities in the external capsules and posterior parts of the internal capsules that have been observed in eastern equine encephalitis (119). A cerebellar-dominant MR imaging pattern has been recognized in Powassan encephalitis, which is associated with a 60% mortality rate (40). Imaging techniques are also useful because they may show temporal lobe lesions suggestive of Herpes simplex encephalitis, and they helpfexclude disorders that can mimic viral encephalitis.
A cerebrospinal fluid analysis is important in establishing a diagnosis of viral encephalitis, and a CT head scan (or MRI scan) should precede the lumbar puncture if there are focal neurologic signs or evidence of increased intracranial pressure. There is usually a cerebrospinal fluid pleocytosis with a modest number of leukocytes that are predominantly mononuclear cells. Cerebrospinal fluid protein is often elevated, and the cerebrospinal fluid glucose is usually normal. Viral cultures on cerebrospinal fluid for arboviruses are usually not positive, although Japanese encephalitis virus may be isolated from cerebrospinal fluid in up to one third of patients (84). However, enteroviruses, lymphocytic choriomeningitis virus, and mumps virus may be isolated from cerebrospinal fluid. Venezuelan equine encephalitis virus, tick-borne encephalitis viruses, and Colorado tick fever virus may be isolated from blood (47; 57). Arboviruses may be cultured from the brain and spinal cord in fatal cases. Rarely, a diagnosis may be made by using brain biopsy (91). Most arboviral infections are usually diagnosed serologically. A serologic diagnosis is commonly made on the basis of a 4-fold or greater rise (or fall) in the titer of viral antibodies (immunofluorescent, hemagglutination inhibition, complement fixation, or neutralizing) during the infection. Both acute and convalescent sera should be obtained, the latter 2 to 6 weeks later. A diagnosis may be made during hospital admission or soon afterward by demonstration of viral specific IgM in the cerebrospinal fluid by capture enzyme immunoassay (15; 58). Assays using polymerase chain reaction amplification are generally less reliable than detection of virus-specific immunoglobulin M in cerebrospinal fluid but may be useful in detecting viral RNA from arboviruses in the cerebrospinal fluid or brain tissues (128; 24; 60; 11). In immunosuppressed patients, serological tests in some cases may be negative, as in a patient with Powassan encephalitis on rituximab (120).
Management
|
• There is no effective antiviral therapy. | |
|
• The role of immunotherapy requires further study. |
No effective antiviral therapy is available for treating patients with arboviral encephalitis. Seizures should be treated with antiepileptic medications, but prophylactic therapy is not necessary. Corticosteroids are of unproven value, and a study did not demonstrate a benefit of high-dose dexamethasone in treating Japanese encephalitis (59). In tick-borne encephalitis, a retrospective study indicated that corticosteroids prolonged the disease duration and did not influence sequelae (76). Therapy with alpha-interferon was not found to improve outcomes in a clinical trial in Vietnamese children with Japanese encephalitis (123). A phase I/IIA trial of intravenous ribavirin therapy for La Crosse encephalitis showed poor penetration into the CSF at a moderate dose and adverse effects at an escalated dose (93); a randomized clinical trial was not recommended. A humanized monoclonal antibody (MGAWN1) has been developed against West Nile virus (100) and was evaluated in a large multicenter clinical trial, but few patients were enrolled and the study was not completed. Intravenous human immunoglobulin from donors in Israel has been used for therapy of West Nile encephalitis (97), but a multicenter, randomized, controlled clinical trial by the Collaborative Antiviral Study Group failed to show efficacy for the treatment of West Nile encephalitis. A small clinical trial showed therapy feasibility in children with suspected Japanese encephalitis using intravenous immunoglobulin (108). The therapeutic use of monoclonal antibodies for arboviral infections may be useful in the future (101). A small pilot study using interferon alpha-2b indicated possible efficacy in St Louis encephalitis, and a prospective, randomized, controlled trial might be warranted (106). However, no specific therapy is of proven benefit for West Nile encephalitis (61) or other arboviral encephalitis. Vigorous supportive therapy and avoidance of complications are important. Monitoring of intracranial pressure and therapy for intracranial hypertension may be necessary in some patients. Respiratory, metabolic, and septic complications may occur in severely ill patients with encephalitis, and patients should be closely monitored for these. Isolation procedures are not necessary; the possible exceptions to this are Venezuelan equine encephalitis and tick-borne encephalitis because of a concern about the potential for transmission by close direct contact (57; 20).
Outcomes
Neurologic sequelae are common in neuroinvasive arboviral infections. About one third of cases of eastern equine encephalitis are fatal, which has the highest mortality rate, and most cases have long-term sequelae. The mortality rate in Powassan virus infections is 19% in adults (69). The other neuroinvasive arboviral infections have lower mortality rates and fewer neurologic sequelae. Patients receiving rituximab therapy or other B-cell-depleting monoclonal antibodies may have a more severe or prolonged clinical course and also an absence of serological response to the infection (71).
Special considerations
Pregnancy
Information on arboviral infections during pregnancy is limited. There have been reports of transplacental transmission of western equine encephalitis virus (27), Venezuelan equine encephalitis (136), West Nile virus (23), Japanese encephalitis virus (90), Colorado tick fever virus (10), and La Crosse encephalitis virus (55). Zika virus infection in pregnant mothers can cause severe congenital abnormalities in fetuses, resulting in microcephaly and other severe CNS abnormalities (64; 118). Congenital infections due to arboviral infections may be much more common than recognized and be responsible for CNS malformations (129).
Anesthesia
There are no special considerations for anesthesia. However, there is evidence that inhalational anesthetics, including halothane and nitrous oxide, promote viral brain invasion and suppress the immune response in experimental West Nile virus infection in mice (73).
Media
References
- 01
- Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K. Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology 2000;55:144-6. PMID 10891928
- 02
- Albrecht P. Pathogenesis of neurotropic arbovirus infections. Curr Top Microbiol Immunol 1968;43:45-91. PMID 4970327
- 03
- Araujo FM, Araujo MS, Nogueira RM, et al. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology 2012;78:736-42. PMID 22357720
- 04
- Artsob H. Powassan encephalitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Vol 4. Boca Raton: CRC Press, 1989:29-49.
- 05
- Asher DM. Persistent tick-borne encephalitis infection in man and monkeys: relation to chronic neurologic disease. In: Kurstak E, editor. Arctic and tropical arboviruses. New York: Academic Press, 1979:179-95.
- 06
- Babi MA, Raleigh T, Shapiro RE, McSherry J, Applebee A. MRI and encephalography in fatal eastern equine encephalitis. Neurology 2014;83:1483. PMID 25313378
- 07
- Bartels S, de BL, Kretzschmar HA, Heckmann JG. Lethal encephalitis caused by the Toscana virus in an elderly patient. J Neurol 2012;259(1):175-7. PMID 21656341
- 08
- Beattie GC, Glaser CA, Sheriff H, et al. Encephalitis with thalamic and basal ganglia abnormalities: etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis 2013;56:825-32. PMID 23196954
- 09
- Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol 1993;33:94-100. PMID 8388191
- 10
- Bowen GS. Colorado tick fever. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Vol 2. Boca Raton: CRC Press, 1988:159-76.
- 11
- Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid (Letter). Lancet 2000;355:1614-5. PMID 10821368
- 12
- Brinker KR, Monath TP. The acute disease. In: Monath TP, editor. St. Louis encephalitis. Washington, DC: American Public Health Association, 1980:503-34.
- 13
- Brito Ferreira ML, Antunes de Brito CA, Moreira AJP, et al. Guillain-Barre syndrome, acute disseminated encephalomyelitis and encephalitis associated with Zika virus infection in Brazil: detection of viral RNA and isolation of virus during late infection. Am J Trop Med Hyg 2017;97(5):1405-9. PMID 29140242
- 14
- Burke DS, Leake CJ. Japanese encephalitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Vol 3. Boca Raton: CRC Press, 1988:63-92.
- 15
- Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 1985;151:1093-9. PMID 2987367
- 16
- Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningoencephalitis. N Engl J Med 2016;374(16):1595-6. PMID 26958738
- 17
- Cavaliere E, Nosadini M, Pelizza MF, Ventura G, Toldo I, Sartori S. Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection: systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis. J Neuroimmunol 2019;332:1-7. PMID 30913507
- 18
- Centers for Disease Control and Prevention. Arthropod-borne and rodent-borne viral diseases. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1985:719:1-116. PMID 3929480
- 19
- Centers for Disease Control and Prevention. Venezuelan equine encephalitis--Columbia, 1995. MMWR Morb Mortal Wkly Rep 1995a;44:721-4. PMID 7565549
- 20
- Centers for Disease Control and Prevention. Update: Venezuelan equine encephalitis-Columbia, 1995. MMWR Morb Mortal Wkly Rep 1995b;44:775-7. PMID 7565561
- 21
- Centers for Disease Control and Prevention. Arboviral infections of the central nervous system: United States, 1996-1997. MMWR Morb Mortal Wkly Rep 1998a;47(25):517-22. PMID 9667823
- 22
- Centers for Disease Control and Prevention. Update: West Nile virus encephalitis--New York, 1999. MMWR Morb Mortal Wkly Rep 1999;48:944-6, 955.
- 23
- Centers for Disease Control and Prevention. Intrauterine West Nile virus infection--New York, 2002. MMWR Morb Mortal Wkly Rep 2002;51(50):1135-6. PMID 12537289
- 24
- Chandler LJ, Borucki MK, Dobie DK, et al. Characterization of La Crosse virus RNA in autopsied central nervous system tissues. J Clin Microbiol 1998;36:3332-6. PMID 9774588
- 25
- Choi EE, Taylor RA. A case of Powassan viral hemorrhagic encephalitis involving bilateral thalami. Clin Neurol Neurosurg 2012;114(2):172-5. PMID 22040725
- 26
- Coleman KJ, Chauhan L, Piquet AL, Tyler KL, Pastula DM. An overview of Jamestown Canyon virus disease. Neurohospitalist 2021;11(3):277-8. PMID 34163560
- 27
- Copps SC, Giddings LE. Transplacental transmission of western equine encephalitis: report of a case. Pediatrics 1959;24:31-3. PMID 13667330
- 28
- Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol 2006;60:286-300. PMID 16983682
- 29
- Deering WM. Neurologic aspects and treatment of La Crosse encephalitis. In: Calisher CH, Thompson WH, editors. California serogroup viruses, proceedings of an international symposium held in Cleveland, Ohio, November 12 and 13, 1982. New York: Alan R. Liss, 1983:187-91.
- 30
- Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997;336:1867-74. PMID 9197215
- 31
- Diaz A, Coffey LL, Burkett-Cadena N, Day JF. Reemergence of St. Louis encephalitis virus in the Americas. Emerg Infect Dis 2018;24(12). PMID 30457961
- 32
- Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis 1999;28:882-90. PMID 10825054
- 33
- Earnest MP, Goolishian HA, Calverley JR, Hayes RO, Hill HR. Neurologic, intellectual, and psychologic sequelae following western encephalitis: a follow-up study of 35 cases. Neurology 1971;21:969-74. PMID 5106260
- 34
- Ebel GD. Update on Powassan virus: emergence of a North American tick-borne flavivirus. Annu Rev Entomol 2010;55:95-110. PMID 19961325
- 35
- Ehrenkranz NJ, Ventura AK. Venezuelan equine encephalitis virus infection in man. Annu Rev Med 1974;25:9-14. PMID 4824504
- 36
- Eldridge BF. Strategies for surveillance, prevention, and control of arbovirus diseases in western North America. Am J Trop Med Hyg 1987;37(Suppl):77S-86S. PMID 2891313
- 37
- Eldridge BF, Glaser C, Pedrin RE, Chiles RE. The first reported case of California encephalitis in more than 50 years. Emerg Infect Dis 2001;7:451-2. PMID 11384526
- 38
- Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis 2009;15:1-7. PMID 19116041
- 39
- Feemster RF. Equine encephalitis in Massachusetts. N Engl J Med 1957;257:701-4. PMID 13477374
- 40
- Finelli PF. MR imaging patterns and prognosis in Powassan virus encephalitis. Neurologist 2024;29(2):103-5. PMID 37839084
- 41
- Finley KH, Riggs N. Convalescence and sequelae. In: Monath TP, editor. St. Louis encephalitis. Washington, DC: American Public Health Association, 1980:535-50.
- 42
- Francy DB. Mosquito control for prevention of California (La Crosse) encephalitis. In: Calisher CH, Thompson WH, editors. California serogroup viruses, proceedings of an international symposium held in Cleveland, Ohio, November 12 and 13, 1982. New York: Alan R. Liss, 1983:365-75.
- 43
- Gasque P. Chikungunya virus infection. In: Jackson AC, editor. Viral infections of the human nervous system. Basel: Springer Basel, 2012:295-315.
- 44
- Gholam BIA, Puksa S, Provias JP. Powassan encephalitis: a case report with neuropathology and literature review. CMAJ 1999;161(11):1419-22. PMID 10906899
- 45
- Ghosh R, Dubey S, Chatterjee S, Kanti Ray B, Benito-León J. Mixed upper and lower motor neuron damage in Japanese encephalitis virus infection. Case Rep Neurol 2020;12(3):482-8. PMID 33568983
- 46
- Gimenez-Richarte A, Ortiz de Salazar MI, Giménez-Richarte MP, et al. Transfusion-transmitted arboviruses: update and systematic review. PLoS Negl Trop Dis 2022;16:e0010843. PMID 36201547
- 47
- Goodpasture HC, Poland JD, Francy DB, Bowen GS, Horn KA. Colorado tick fever: clinical, epidemiologic, and laboratory aspects of 228 cases in Colorado in 1973-1974. Ann Intern Med 1978;88:303-10. PMID 204240
- 48
- Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008;371(9611):500-9. PMID 18262042
- 49
- Granger DM, Lopansri BK, Butcher D, et al. Tick-borne encephalitis among U.S. travelers to Europe and Asia - 2000-2009. MMWR Morb Mortal Wkly Rep 2010;59:335-8. PMID 20339345
- 50
- Griffin DE. Alphavirus pathogenesis and immunity. In: Schlesinger S, Schlesinger M, editors. Comprehensive virology: the togaviridae and flaviviridae. New York: Plenum, 1986:209-49.
- 51
- Guo H, Sun L, Shen X, Hu W. A retrospective study of the clinical characteristics of Japanese encephalitis in adults. J Integr Neurosci 2022;21:125. PMID 36137966
- 52
- Handique SK, Das RR, Barman K, et al. Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. AJNR Am J Neuroradiol 2006;27:1027-31. PMID 16687537
- 53
- Hanson RP. An epizootic of equine encephalomyelitis that occurred in Massachusetts in 1831. Am J Trop Med Hyg 1957;6:858-62. PMID 13470206
- 54
- Hills SL, Poehling KA, Chen WH, Staples JE. Tick-borne encephalitis vaccine: recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep 2023;72:1-29. PMID 37943707
- 55
- Hinckley A, Hall A. Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007. MMWR Morb Mortal Wkly Rep 2009;58(1):4-7. PMID 19145220
- 56
- Hinten SR, Beckett GA, Gensheimer KF, et al. Increased recognition of Powassan encephalitis in the United States, 1999-2005. Vector Borne Zoonotic Dis 2008;8:733-40. PMID 18959500
- 57
- Ho M. Acute viral encephalitis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Vol 34. New York: North-Holland Publ, 1978:63-81.
- 58
- Hofmann H, Heinz FX, Dippe H, Kunz C. Tick-borne encephalitis: a simple method for detection of antibody production in the brain. Zentralbl Bakteriol Mikrobiol Hyg 1985;260(1):132-8. PMID 3904279
- 59
- Hoke CH Jr, Vaughn DW, Nisalak A, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992;165(4):631-7. PMID 1313068
- 60
- Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system. N Engl J Med 1999;340:483-4. PMID 9988625
- 61
- Jackson AC. Therapy of West Nile virus infection (Editorial). Can J Neurol Sci 2004;31(2):131-4. PMID 15198433
- 62
- Jackson AC, Johnson RT. Aseptic meningitis and acute viral encephalitis. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology. Vol 56. Viral disease. Amsterdam: Elsevier, 1989:125-48.
- 63
- Jackson AC, Rossiter JP. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice. Acta Neuropathol 1997;93:349-53. PMID 9113200
- 64
- Johansson MA, Teran-Romero L, Reefhuis J, Gilboa SM, Hills SL. Zika and the risk of microcephaly. N Engl J Med 2016;375:1-4. PMID 27222919
- 65
- Johnson RT. Acute encephalitis. Clin Infect Dis 1996;23:219-24. PMID 8842253
- 66
- Johnson RT. Viral infections of the nervous system. 2nd ed. Philadelphia: Lippincott-Raven, 1998:87-132.
- 67
- Johnson RT, Griffin DE, Gendelman HE. Postinfectious encephalomyelitis. Semin Neurol 1985;5:180-90.
- 68
- Kaiser R. Tick-borne encephalitis: clinical findings and prognosis in adults. Wien Med Wochenschr 2012;162:239-43. PMID 22695809
- 69
- Kakoullis L, Vaz VR, Kaur D, Kakoulli S, Panos G, Chen LH, Behlau I. Powassan virus infections: a systematic review of published cases. Trop Med Infect Dis 2023;8:508. PMID 38133440
- 70
- Kalita J, Misra UK. Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 2000;174:3-8. PMID 10704974
- 71
- Kapadia RK, Staples JE, Gill CM, et al. Severe arboviral neuroinvasive disease in patients on rituximab therapy: a review. Clin Infect Dis 2022;ciac766. PMID 36103602
- 72
- Karzon DT. The enteroviruses and the aseptic meningitis syndrome. Q Rev Pediatr 1959;14:78-90. PMID 13658357
- 73
- Katz Y, Lustig S, Ben Shlomo I, Kobiler D, Ben Nathan D. Inhalation anesthetic-induced neuroinvasion by an attenuated strain of West Nile virus in mice. J Med Virol 2002;66:576-80. PMID 11857540
- 74
- Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004;61(8):1210-20. PMID 15313835
- 75
- Komar N, Spielman A. Emergence of eastern encephalitis in Massachusetts. Ann N Y Acad Sci 1994;740:157-68. PMID 7840447
- 76
- Krawczuk K, Czupryna P, Pancewicz S, Oldak E, Moniuszko-Malinowska A. Comparison of tick-borne encephalitis between children and adults - analysis of 669 patients. J Neurovirol 2020;26(4):565-71. PMID 32524423
- 77
- Krow-Lucal ER, Lindsey NP, Fischer M, Hills SL. Powassan virus disease in the United States, 2006-2016. Vector Borne Zoonotic Dis 2018;18(6):286-90. PMID 29652642
- 78
- Kumar S, Misra UK, Kalita J, Salwani V, Gupta RK, Gujral R. MRI in Japanese encephalitis. Neuroradiology 1997;39:180-4. PMID 9106289
- 79
- Kwasnik M, Rola J, Rozek W. Tick-brne encephalitis - review of the current status. J Clin Med 2023;12:6603. PMID 37892741
- 80
- Lenka A, Kamat A, Mittal SO. Spectrum of movement disorders in patients with neuroinvasive West Nile virus infection. Mov Disord Clin Pract 2019;6:426-33. PMID 31392241
- 81
- Lewis J, Wesselingh SL, Griffin DE, Hardwick JM. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol 1996;70:1828-35. PMID 8627707
- 82
- Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003;53(6):703-10. PMID 12783415
- 83
- Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile virus disease, United States, 2008-2010. Am J Trop Med Hyg 2012;87:179-84. PMID 22764311
- 84
- Lowry PW. Arbovirus encephalitis in the United States and Asia. J Lab Clin Med 1997;129:405-11. PMID 9104883
- 85
- Luby JP. St. Louis encephalitis. Epidemiol Rev 1979;1:55-73. PMID 398269
- 86
- Luo H, Ding X, Li Y, et al. Clinical characteristics of children with anti-N-Methyl-d-Aspartate receptor encephalitis after Japanese encephalitis. Pediatr Neurol 2022;130:46-52. PMID 35325660
- 87
- Mancera-Paez O, Roman GC, Pardo-Turriago R, Rodriguez Y, Anaya JM. Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis post-Zika: a case report and review of the pathogenic role of multiple arboviral immunity. J Neurol Sci 2018;395:47-53. PMID 30292020
- 88
- Marfin AA, Eidex RS, Kozarsky PE, Cetron MS. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 2005;19:151-68. PMID 15701552
- 89
- Marjelund S, Tikkakoski T, Tuisku S, Raisanen S. Magnetic resonance imaging findings and outcome in severe tick-borne encephalitis. Report of four cases and review of the literature. Acta Radiol 2004;45(1):88-94. PMID 15164786
- 90
- Mathur A, Tandon HO, Mathur KR, Sarkari NB, Singh UK, Chaturvedi UC. Japanese encephalitis virus infection during pregnancy. Indian J Med Res 1985;81:9-12. PMID 2985501
- 91
- McJunkin JE, Khan R, los Reyes EC, et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics 1997;99:261-7. PMID 9024460
- 92
- McJunkin JE, los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001;344:801-7. PMID 11248155
- 93
- McJunkin JE, Nahata MC, De Los Reyes EC, et al. Safety and pharmacokinetics of ribavirin for the treatment of La Crosse encephalitis. Pediatr Infect Dis J 2011;30:860-5. PMID 21544005
- 94
- Misra UK, Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurol Scand 1997a;96:114-7. PMID 9272188
- 95
- Misra UK, Kalita J. A comparative study of Japanese and herpes simplex encephalitides. Electromyogr Clin Neurophysiol 1998;38:41-6. PMID 9532432
- 96
- Monath TP. Arthropod-borne encephalitides in the Americas. Bull World Health Organ 1979;57:513-33. PMID 93518
- 97
- Nathan DB, Samina I, Orr N. High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis. Hum Vaccin 2010;6:279-81. PMID 19946208
- 98
- Nóbrega PR, Morais NMM, Braga-Neto P, et al. NMDAR encephalitis associated with acute chikungunya virus infection: a new trigger? Front Pediatr 2020;8:176. PMID 32426307
- 99
- Okuno T. An epidemiological review of Japanese encephalitis. World Health Stat Q 1978;31:120-33. PMID 214963
- 100
- Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 2005;11:522-30. PMID 15852016
- 101
- Ormundo LF, Barreto CT, Tsuruta LR. Development of therapeutic monoclonal antibodies for emerging arbovirus infections. Viruses 2023;15:2177. PMID 38005854
- 102
- Pastula DM, Durrant JC, Smith DE, Beckham JD, Tyler KL. Zika virus disease for the neurointensivist. Neurocrit Care 2017;26:457-63. PMID 27995511
- 103
- Picheca C, Yogendrakumar V, Brooks JI, Torres C, Pringle E, Zwicker J. Polio-like manifestation of Powassan virus infection with anterior horn cell involvement, Canada. Emerg Infect Dis 2019;25:1609-11. PMID 31158072
- 104
- Piliero PJ, Brody J, Zamani A, Deresiewicz RL. Eastern equine encephalitis presenting as focal neuroradiographic abnormalities: case report and review. Clin Infect Dis 1994;18:985-8. PMID 8086564
- 105
- Przelomski MM, O'Rourke E, Grady GF, Berardi VP, Markley HG. Eastern equine encephalitis in Massachusetts: a report of 16 cases, 1970-1984. Neurology 1988;38:736-9. PMID 3362371
- 106
- Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis 2004;190:1084-7. PMID 15319857
- 107
- Raval M, Singhal M, Guerrero D, Alonto A. Powassan virus infection: case series and literature review from a single institution. BMC Res Notes 2012;5:594:594-5. PMID 23111001
- 108
- Rayamajhi A, Nightingale S, Bhatta NK, et al. A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal. PLoS One 2015;10(4):e0122608. PMID 25886645
- 109
- Reimann CA, Hayes EB, DiGuiseppi C, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg 2008;79:974-9. PMID 19052314
- 110
- Reisen WK, Monath TP. Western equine encephalomyelitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Vol 5. Boca Raton: CRC Press, 1989:89-137.
- 111
- Sampson BA, Ambrosi C, Charlot A, Reiber K, Veress JF, Armbrustmacher V. The pathology of human West Nile virus infection. Hum Pathol 2000;31:527-31. PMID 10836291
- 112
- Sarkar N, Roy BK, Das SK, Roy T, Dhibar T, Ghorai S. Bilateral intracerebral haemorrhages: an atypical presentation of Japanese encephalitis. J Assoc Physicians India 2005;53:144-6. PMID 15847037
- 113
- Sejvar JJ. Zika virus and other emerging arboviral central nervous system infections. Continuum (Minneap Minn) 2018;24(5, Neuroinfectious Disease):1512-34. PMID 30273250
- 114
- Sejvar JJ, Davis LE, Szabados E, Jackson AC. Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J Neurovirol 2010;16:93-100. PMID 20166837
- 115
- Sejvar JJ, Fischer M. West Nile virus infection. In: Jackson AC, editor. Viral infections of the human nervous system. Basel: Springer Basel, 2012:237-69.
- 116
- Shope RE. The discovery of arbovirus diseases. Ann N Y Acad Sci 1994;740:138-45. PMID 7840445
- 117
- Smorodintsev AA. Tick-borne spring-summer encephalitis. Prog Med Virol 1958;1:210-48. PMID 13579009
- 118
- Soares de Oliveira-Szejnfeld P, Levine D, Melo AS. Congenital brain abnormalities and Zika virus: what the radiologist can expect to see prenatally and postnatally. Radiology 2016;281:203-18. PMID 27552432
- 119
- Solis MB, Albuja AC, Villamar MF. "Parenthesis sign" in Eastern equine encephalitis. Arq Neuropsiquiatr 2022;80:975-6. PMID 3621125
- 120
- Solomon IH, Spera KM, Ryan SL, et al. Fatal Powassan encephalitis (deer tick virus, lineage II) in a patient with fever and orchitis receiving rituximab. JAMA Neurol 2018;75(6):746-50. PMID 29554185
- 121
- Solomon T. New vaccines for Japanese encephalitis. Lancet Neurol 2008;7(2):116-8. PMID 18207104
- 122
- Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000;68:405-15. PMID 10727474
- 123
- Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003;361:821-6. PMID 12642049
- 124
- Tauber E, Kollaritsch H, Korinek M, et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007;370(9602):1847-53. PMID 18061060
- 125
- Tavakoli NP, Wang H, Dupuis M, et al. Fatal case of deer tick virus encephalitis. N Engl J Med 2009;360:2099-107. PMID 19439744
- 126
- Teleron AL, Rose BK, Williams DM, Kemper SE, McJunkin JE. La Crosse encephalitis: an adult case series. Am J Med 2016. PMID 27086496
- 127
- Tian M, Li J, Lei W, Shu X. Japanese encephalitis virus-induced anti-N-methyl-D-aspartate receptor encephalitis: a case report and review of literature. Neuropediatrics 2019;50(2):111-5. PMID 30620950
- 128
- Tomazic J, Poljak M, Popovic P, et al. Tick-borne encephalitis: possibly a fatal disease in its acute stage. PCR amplification of TBE RNA from postmortem brain tissue. Infection 1997;25:41-3. PMID 9039538
- 129
- Tsai TF. Congenital arboviral infections: something new, something old. Pediatrics 2006;117:936-9. PMID 16510678
- 130
- Turell MJ. Horizontal and vertical transmission of viruses by insect and tick vectors. In: Monath TP, editor. The arboviruses: epidemiology and ecology. Vol 1. Boca Raton: CRC Press, 1988:127-52.
- 131
- Turtle L, Solomon T. Japanese encephalitis virus infection. In: Jackson AC, editor. Viral infections of the human nervous system. Basel: Springer Basel, 2012:271-93.
- 132
- Verma R, Sahu R, Holla V. Neurological manifestations of dengue infection: a review. J Neurol Sci 2014;346:26-34. PMID 25220113
- 133
- Villari P, Spielman A, Komar N, McDowell M, Timperi RJ. The economic burden imposed by a residual case of eastern encephalitis. Am J Trop Med Hyg 1995;52:8-13. PMID 7856830
- 134
- Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004;10:1366-73. PMID 15558055
- 135
- Weaver OM, Pieper S, Kurland R. Japanese encephalitis, sequelae. Neurology 1958;8:888-9. PMID 13590406
- 136
- Wenger F. Venezuelan equine encephalitis. Teratology 1977;16:359-62. PMID 413206
- 137
- Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved Herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med 1977;297:289-94. PMID 195208
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Author
-
Alan C Jackson MD
Dr. Jackson of Lake of the University of Calgary has no relevant financial relationships to disclose.
See Profile
Editor
-
John E Greenlee MD
Dr. Greenlee of the University of Utah School of Medicine has no relevant financial relationships to disclose.
See Profile
Patient Profile
- Age range of presentation
-
- 0 month to 65+ years
- Sex preponderance
-
- male=female
- Heredity
-
- none
- Population groups selectively affected
-
- none selectively affected
- Occupation groups selectively affected
-
- none selectively affected
ICD & OMIM codes
- ICD-11
-
- Arthropod-borne viral fever, virus unspecified: 1D4Z
- Eastern equine encephalitis: 1C84
- Tick-borne encephalitis, unspecified: 1C8G.Z
- Venezuelan equine encephalitis: 1C8C
- Viral encephalitis, not elsewhere classified: 1C80
- Western equine encephalitis: 1C83
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Infectious Disorders
Genital herpes: neurologic complications
Nov. 15, 2024
-
Infectious Disorders
Zika virus: neurologic complications
Oct. 08, 2024
-
Infectious Disorders
Gram-negative bacillary meningitis
Sep. 13, 2024
-
Infectious Disorders
Pneumococcal meningitis
Sep. 03, 2024
-
Neuroimmunology
HTLV-1 associated myelopathy
Aug. 29, 2024
-
Infectious Disorders
Infective endocarditis
Aug. 27, 2024
-
Infectious Disorders
Japanese encephalitis
Aug. 27, 2024